Biotech RadarJobs updated

COMPANY

Terrestrial Bio

HQ: Woburn, MA source · terrestrialbio.com ↗

Clinical Phase 1

21 open jobs · last seen Oct 23, 2026 · 3 sources

Terrestrial is developing the Tacterra™ microarray patch (MAP) platform, capable of delivering a wide range of therapies. From company website Source · Oct 12, 2026

Keywords: Overweight and/or Obesity Influenza VX-201

Profile checked Oct 10, 2026

21Open jobs2Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
QC Analyst / Research Associate, Chromatography FocusWoburn, MA, United StatesOct 22, 2026Oct 8, 2026
Technician, Product DevelopmentWoburn, MA, United StatesOct 15, 2026Oct 16, 2026
Quality Assurance Specialist II, Device Design ControlWoburn, MA, United StatesOct 13, 2026Oct 14, 2026
Associate Director, Process EngineeringWoburn, MA, United StatesOct 9, 2026Oct 8, 2026
Preclinical Study ManagerWoburn, MA, United StatesOct 6, 2026Oct 8, 2026

See all 21 jobs

Funding and NIH signals

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

Raises announced in these releases: $59M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Timeline

  1. Board tracked Radar started tracking this company’s job board (21 open jobs at last check). source ↗
  2. Trial start Phase 1: Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants source ↗
  3. Raise Series C · $50M source ↗
  4. Raise Undisclosed round · $9M source ↗
  5. Trial start 1: Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Open jobs 21

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
QC Analyst / Research Associate, Chromatography FocusWoburn, MA, United StatesOct 22, 2026Oct 8, 2026Entry
Technician, Product DevelopmentWoburn, MA, United StatesOct 15, 2026Oct 16, 2026Not stated
Quality Assurance Specialist II, Device Design ControlWoburn, MA, United StatesOct 13, 2026Oct 14, 2026Mid
Associate Director, Process EngineeringWoburn, MA, United StatesOct 9, 2026Oct 8, 2026Senior
Preclinical Study ManagerWoburn, MA, United StatesOct 6, 2026Oct 8, 2026Mid
Research Associate, Environmental MonitoringWoburn, MA, United StatesOct 6, 2026Oct 8, 2026Mid
Scientist, PreclinicalWoburn, MA, United StatesOct 6, 2026Oct 8, 2026Entry
Research Associate, Functional & Biological AssaysWoburn, MA, United StatesOct 6, 2026Oct 8, 2026Mid
Director, Program ManagementWoburn, MA, United StatesOct 1, 2026Oct 8, 2026Senior
Engineer I/II, Process DevelopmentWoburn, MA, United StatesSep 25, 2026Oct 8, 2026Mid
Quality Engineer, Analytical Development & Quality Control - Mechanical TestingWoburn, MA, United StatesSep 14, 2026Oct 8, 2026Entry
QC Analyst / Research Associate, Fluidic PropertiesWoburn, MA, United StatesSep 14, 2026Oct 8, 2026Entry
QA Operations Specialist IWoburn, MA, United StatesAug 28, 2026Oct 8, 2026Entry
Principal Scientist / Associate Director, Process Analytical Technology (PAT) LeadWoburn, MA, United StatesAug 28, 2026Oct 8, 2026Senior
Senior / Principal Scientist Analytical Method Development LeadWoburn, MA, United StatesAug 28, 2026Oct 8, 2026Mid
Senior Director, Data & AIWoburn, MA, United StatesAug 21, 2026Oct 8, 2026Senior
Senior Process EngineerWoburn, MA, United StatesAug 18, 2026Oct 8, 2026Senior
Engineer II/III , FormulationWoburn, MA, United StatesAug 5, 2026Oct 8, 2026Mid
Sr Technician, ManufacturingWoburn, MA, United StatesAug 4, 2026Oct 8, 2026Senior
Associate Director, Environmental Health & SafetyWoburn, MA, United StatesAug 3, 2026Oct 8, 2026Senior
Technician, FormulationWoburn, MA, United StatesJul 31, 2026Oct 8, 2026Entry

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT07673900Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese ParticipantsPhase 1RecruitingJun 15, 2026Feb 10, 2027 (estimated)
NCT06125717Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP1CompletedJul 2, 2022Mar 13, 2023 (actual)
Feedback